Cardiovascular
Trusted solutions for heart health, ensuring safety and efficacy in cardiovascular care.
All therapy areasCardiovascular disease remains the single largest cause of death worldwide, and the medicines that manage it are taken every day for decades. That makes consistency — not novelty — the hardest problem in the category. Graviti's cardiovascular portfolio is built around release profiles that behave identically in the ten-thousandth batch as in the first.
Antihypertensives, lipid-lowering agents, antiplatelets and heart-failure therapies, formulated for once-daily adherence and stable plasma profiles.
Laser-drilled osmotic controlled-release systems and precision functional coating let us hold tight dissolution windows across the full shelf life.
Built for cardiovascular — batch after batch.
8 products in cardiovascular
- Tablet
Gravicor AM
Amlodipine
2.5 mg5 mg10 mg - Tablet
Gravicor TL
Telmisartan
20 mg40 mg80 mg - Film-coated tablet
Gravicor TL-AM
Telmisartan + Amlodipine
40/5 mg80/5 mg40/10 mg - Film-coated tablet
Lipigrav
Rosuvastatin
5 mg10 mg20 mg40 mg - Hard gelatin capsule
Lipigrav F
Rosuvastatin + Fenofibrate
10/160 mg20/160 mg - Modified-release tablet
Cardigrav XR
Metoprolol Succinate
25 mg50 mg100 mg - Film-coated tablet
Plavigrav
Clopidogrel
75 mg150 mg - Osmotic controlled-release tablet
Nitrograv OSM
Nifedipine
30 mg60 mg90 mg